Trade Biogen Inc. - BIIB CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.35 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 136.96 |
| Open | 138.97 |
| 1-Year Change | -36.61% |
| Day's Range | 138.73 - 141.06 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 140.53 | 3.21 | 2.34% | 137.32 | 141.40 | 137.32 |
| Feb 20, 2025 | 136.96 | 0.01 | 0.01% | 136.95 | 138.73 | 136.37 |
| Feb 19, 2025 | 136.52 | 0.42 | 0.31% | 136.10 | 137.43 | 134.72 |
| Feb 18, 2025 | 136.48 | -1.47 | -1.07% | 137.95 | 138.82 | 135.80 |
| Feb 14, 2025 | 136.83 | -2.82 | -2.02% | 139.65 | 141.49 | 135.80 |
| Feb 13, 2025 | 138.33 | 5.87 | 4.43% | 132.46 | 138.96 | 132.46 |
| Feb 12, 2025 | 133.24 | -3.16 | -2.32% | 136.40 | 136.89 | 128.46 |
| Feb 11, 2025 | 139.23 | -1.14 | -0.81% | 140.37 | 141.07 | 138.58 |
| Feb 10, 2025 | 142.35 | 0.80 | 0.57% | 141.55 | 142.44 | 139.95 |
| Feb 7, 2025 | 141.27 | -0.33 | -0.23% | 141.60 | 143.52 | 140.49 |
| Feb 6, 2025 | 142.17 | -1.86 | -1.29% | 144.03 | 144.95 | 141.56 |
| Feb 5, 2025 | 145.19 | 3.14 | 2.21% | 142.05 | 146.75 | 142.05 |
| Feb 4, 2025 | 142.28 | 1.25 | 0.89% | 141.03 | 143.91 | 140.97 |
| Feb 3, 2025 | 142.15 | 0.52 | 0.37% | 141.63 | 144.34 | 140.92 |
| Jan 31, 2025 | 143.65 | -1.31 | -0.90% | 144.96 | 147.22 | 143.16 |
| Jan 30, 2025 | 145.91 | 0.31 | 0.21% | 145.60 | 147.51 | 144.70 |
| Jan 29, 2025 | 144.19 | -0.73 | -0.50% | 144.92 | 147.14 | 143.00 |
| Jan 28, 2025 | 145.23 | -2.37 | -1.61% | 147.60 | 148.15 | 144.95 |
| Jan 27, 2025 | 148.56 | 2.05 | 1.40% | 146.51 | 149.42 | 145.75 |
| Jan 24, 2025 | 146.04 | 2.89 | 2.02% | 143.15 | 146.22 | 141.67 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Biogen Company profile
Biogen Inc. (BIIB) is a biotechnology company in the field of neurological and neurodegenerative diseases.
Established in 1978 and headquartered in Cambridge, Massachusetts, Biogen has devoted its scientific research to defeating neurological diseases, like multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
With the aid of some of the world’s leading neuroscientists and neurologists, Biogen has sought treatments against common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
The use of advanced technologies and engineering skills has enabled Biogen to bring effective medicines to the market. The company’s products include SPINRAZA for the treatment of SMA; TECFIDERA, AVONEX, FAMPYRA, VUMERITY and TYSABRI for multiple sclerosis; ADUHELM for Alzheimer’s disease; and FUMADERM for the treatment of severe plaque psoriasis.
Biogen has made an agreement with Genentech, a member of the Roche Group for business and financial rights, with respect to RITUXAN, GAZYVA and OCREVUS. It’s constantly looking at ways to improve its research and development to compete against other biotech giants like Pfizer Inc (PFE), Johnson & Johnson (JNJ) and Amgen (AMGN).
Biogen went public in September 1991. It trades on the Nasqaq under the ticker ‘BIIB’.
| Industry: | Biopharmaceuticals |
225 Binney Street
CAMBRIDGE
MASSACHUSETTS 02142
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com